Company / Free Cash Flow per Share
Corcept Therapeutics Incorporated Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.35
FY2025
5-year range
$1.16 / $1.90
FY2021-FY2025
Trend
-28.9%
vs FY2024
Sector context
#41 of 192
Health Care
What the data says
Corcept Therapeutics Incorporated's free cash flow per share of $1.35 is higher than 79% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.25 in FY2016 to $1.90 in FY2024.
Based on SEC 10-K filings.
1.35 in FY2025 with a 5-year CAGR of +6.0%. Top quartile in the Health Care sector.
Improved from $1.17 to $1.35 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -1.8%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Sector benchmark
-59.4% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 28.9% year-over-year.
- Ranks #41 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.35 | -28.9% |
| FY2024 | $1.90 | +61.6% |
| FY2023 | $1.17 | -17.5% |
| FY2022 | $1.42 | +23.0% |
| FY2021 | $1.16 | +14.9% |
| FY2020 | $1.01 | +91.4% |
| FY2019 | $0.53 | +231.7% |
| FY2018 | $0.16 | -70.5% |
| FY2017 | $0.54 | +313.7% |
| FY2016 | -$0.25 | -918.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026